Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 5/20 | 0.83 |
| ▸ | GNB1 | P62873 | 5/20 | 0.83 |
| ▸ | P2RY4 | P51582 | 9/20 | 0.76 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.74 |
| ▸ | P2RY12 | Q9H244 | 8/20 | 0.74 |
| ▸ | P2RY2 | P41231 | 7/20 | 0.74 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.74 |
| ▸ | CDK2 | P24941 | 2/20 | 0.74 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.74 |
| ▸ | ENTPD1 | P49961 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29357302 | 0.99 | GNG2 (0.85) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL791019 | 0.99 | GNG2 (0.85) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL13213975 | 0.96 | GNG2 (0.86) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL13021512 | 0.95 | GNG2 (0.92) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL3019527 | 0.93 | GNG2 (0.77) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL3029899 | 0.92 | GNG2 (0.97) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL13214010 | 0.92 | GNG2 (0.78) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL3026032 | 0.91 | GNG2 (0.82) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL3021101 | 0.91 | GNG2 (0.82) | GNG2GNB1P2RY4PHLPP2CYP1A2 | |
| SCHEMBL2778161 | 0.91 | GNG2 (1.00) | GNG2GNB1P2RY4PHLPP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616449-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | Dundalk Institute of Technology (IE) | 2013-07-24 | — | — | EP | claimed |
| WO-2012035122-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2012-03-22 | — | — | WO | claimed |
| JP-4750804-B2 | — | — | 2011-08-17 | — | — | JP | claimed |
| US-20080306026-A1 | Capsule Formulation | SYNGENTA CROP PROTECTION LLC | 2008-12-11 | — | — | US | claimed |
| JP-2008531514-A | — | — | 2008-08-14 | — | — | JP | claimed |
| EP-1850664-A2 | PESTICIDAL CAPSULE FORMULATION | Syngeta Participations AG (CH) | 2007-11-07 | — | — | EP | claimed |
| WO-2006089747-A2 | PRESTICIDAL CAPSULE FORMULATION | SYNGENTA PARTICIPATIONS AG (CH) | 2006-08-31 | — | — | WO | claimed |
| CN-110093063-B | Magenta dye-based ink composition, ink set, and method for improving print quality of magenta dye-based ink composition | 船井电机株式会社 | 2022-05-17 | — | — | CN | disclosed |
| CN-108271350-B | Ink set and ink jet printing method | 船井电机株式会社 | 2021-05-28 | — | — | CN | disclosed |
| US-9877940-B2 | Anthraquinone compounds and their uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2018-01-30 | — | — | US | disclosed |
| EP-2129653-B1 | NOVEL P2Y12 RECEPTOR ANTAGONISTS | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2016-08-25 | — | — | US | disclosed |
| US-9204630-B2 | Capsule formulation | SYNGENTA PARTICIPATIONS AG (CH) | 2015-12-08 | — | — | US | disclosed |
| US-20100210654-A1 | NOVEL P2Y12 RECEPTOR ANTAGONISTS | RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONN (DE) | 2010-08-19 | — | — | US | disclosed |
| US-20100086603-A1 | COMPOSITION FOR PHOTOPROTECTION | SYNGENTA CROP PROTECTION, INC. (US) | 2010-04-08 | — | — | US | disclosed |
| US-20080306026-A1 | Capsule Formulation | SYNGENTA CROP PROTECTION LLC | 2008-12-11 | — | — | US | disclosed |
| EP-1967513-A1 | Novel P2Y12 receptor antagonists | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2008-09-10 | — | — | EP | disclosed |
| EP-1850664-A2 | PESTICIDAL CAPSULE FORMULATION | Syngeta Participations AG (CH) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006089747-A2 | PRESTICIDAL CAPSULE FORMULATION | SYNGENTA PARTICIPATIONS AG (CH) | 2006-08-31 | — | — | WO | disclosed |
| US-4289496-A | LOW LIQUID TO MATERIAL RATIO RESULTING IN UNIFORMITY OF FINISHING | SANDOZ LTD. (CH) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210654-A1 | NOVEL P2Y12 RECEPTOR ANTAGONISTS | P2RY12, P2RY11, P2RY13 | GNG2 233/4885GNB1 314/4885P2RY4 8/4885 |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | MYLK, MYLK2, MYH10 | GNG2 345/4885GNB1 201/4885P2RY4 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.